Nabla Bio
@nablabio
Followers
453
Following
43
Media
2
Statuses
14
Antibodies designed, not discovered. Learn more at https://t.co/eqRIJxp7JJ
Joined July 2020
Alli will be giving a talk about some of our latest results on antibody design for GPCRs, and the protein production and characterization challenges that go along with that at PEGS Boston 9AM Monday.
0
3
8
RT @khoslaventures: Rockets, AI weather balloons, self-driving trucks… just a few of the KV companies that made @FastCompany’s Most Innovat….
0
3
0
RT @SurgeBiswas: Tech report of our de novo antibody design platform, JAM, is now up on biorxiv! We added new results showing JAM-generated….
0
59
0
Our own Adithya Paramasivam will be giving a talk on our work in de novo antibody design at the BioLogic Summit in San Diego next week. Looks like it will be a great event!
0
3
5
RT @SurgeBiswas: great and thorough post on one way we @nablabio are designing antibodies to multipass membrane proteins, a high-impact but….
0
3
0
RT @PearlF: AI investor @dreidco of @ZettaVentures(@NOETIK_ai & @nablabio in portfolio) posted ahead of #JPM25 on what he's paying attentio….
0
3
0
RT @SurgeBiswas: I’m speaking today at @PEGSboston, 5:10 pm, Eng Antibodies. Talk will cover new “solMPMP” tech from @nablabio where we use….
0
26
0
RT @fran_anastas: Excited to share @nablabio is partnering with 3 of the world’s largest pharma cos to use integrated AI and wet-lab tech t….
0
40
0
Today we announce the close of a $26M Series A financing, led by @radicalvcfund with participation from all existing investors, and pharmaceutical collaborations with @AstraZeneca, @bmsnews, and @TakedaPharma. Thanks to @endpts for breaking our news.
0
11
43
RT @sethbannon: Introducing the Spinout Playbook, a free guide to spinning a startup out of academia. Why is this….
0
179
0
RT @SurgeBiswas: Beep boop 🤖 Very excited to share two new computational roles at Nabla!. - 3D / Structural ML Scientist.- Software Enginee….
0
21
0
RT @benchling: “We’re in the first five years of developability being recognized as one of the main reasons antibodies are failing in the c….
0
2
0